Ken Griffin’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-261,200
| Closed | -$5.27M | – | 15399 |
|
|
2021
Q3 | $5.27M | Sell |
261,200
-72,328
| -22% | -$2M | ﹤0.01% | 4205 |
|
|
2021
Q2 | $12.4M | Sell |
333,528
-154,975
| -32% | -$4.75M | ﹤0.01% | 2745 |
|
|
2021
Q1 | $12.5M | Sell |
488,503
-1,415,275
| -74% | -$36.1M | ﹤0.01% | 2650 |
|
|
2020
Q4 | $41.9M | Buy |
1,903,778
+198,906
| +12% | +$4.38M | 0.01% | 1094 |
|
|
2020
Q3 | $30.7M | Buy |
1,704,872
+723,720
| +74% | +$15M | 0.01% | 1201 |
|
|
2020
Q2 | $24.9M | Sell |
981,152
-1,045,646
| -52% | -$22.5M | 0.01% | 1311 |
|
|
2020
Q1 | $37.2M | Sell |
2,026,798
-13,125
| -0.6% | -$255K | 0.02% | 796 |
|
|
2019
Q4 | $44.9M | Buy |
2,039,923
+108,455
| +6% | +$2.18M | 0.02% | 836 |
|
|
2019
Q3 | $27.7M | Sell |
1,931,468
-253,941
| -12% | -$3.63M | 0.01% | 1193 |
|
|
2019
Q2 | $34.4M | Buy |
2,185,409
+163,799
| +8% | +$2.23M | 0.02% | 970 |
|
|
2019
Q1 | $29.6M | Buy |
2,021,610
+20,911
| +1% | +$240K | 0.01% | 1030 |
|
|
2018
Q4 | $21.4M | Buy |
2,000,699
+50,504
| +3% | +$664K | 0.01% | 1186 |
|
|
2018
Q3 | $29.8M | Buy |
1,950,195
+237,880
| +14% | +$3.46M | 0.01% | 1088 |
|
|
2018
Q2 | $21M | Buy |
1,712,315
+1,541,574
| +903% | +$19.4M | 0.01% | 1269 |
|
|
2018
Q1 | $1.63M | Buy |
+170,741
| New | +$1.84M | ﹤0.01% | 4045 |
|
|
2015
Q2 | – | Sell |
-10,183
| Closed | -$245K | – | 9221 |
|
|
2015
Q1 | $245K | Buy |
+10,183
| New | +$229K | ﹤0.01% | 5930 |
|
Other funds holding DRNA
Ken Griffin's DRNA Position: Q4 2021 in Review
Ken Griffin sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 261,200 shares — an estimated $5.27M sold.
Ken Griffin first reported a position in DRNA in Q1 2015 and held it in 16 quarters. The position peaked at $44.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Ken Griffin reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Ken Griffin sold 261,200 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $5.27M.
- Ken Griffin first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 16 quarters.
- Ken Griffin's Dicerna Pharmaceuticals, Inc. position peaked at $44.9M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.